New President at IPHA
Aidan Lynch, Vice President and General Manager of GSK (Ireland) Limited, has been elected as President of the Irish Pharmaceutical Healthcare Association (IPHA).
In this position, Aidan will represent the research-based pharmaceutical industry in Ireland whose companies are discovering and manufacturing innovative medicines that enhance and save lives.
In addition to his board duties at IPHA, Aidan is a member of the Board of Barretstown. He has been a council member of Dublin Chamber of Commerce since 2012 and was until very recently a Board Member of the British Irish Chamber of Commerce, where he also previously held the role of President.
Commenting on his election, Aidan said: “I am excited to be taking up the Presidency of IPHA at such an important time for our industry. Our industry, made up of pharmaceutical innovators, has a major stake in Ireland’s future. Our medicines are helping people live longer, healthier lives; our scientists are discovering tomorrow’s cures; and we are creating high-value jobs in a fast-growing economy. But we face challenges. Among these is closing the gap between access and innovation, as Irish patients are still not getting access to the innovative medicines we make fast enough.
Partnership will be a key theme of my Presidency, as we focus on partnering with government and policy makers to speed up patient access to innovative medicines and ensure a sustainable future for Ireland as a world leader in the discovery and manufacture of medicines.”
Ends
